William Charles Banyai Ph.D.
Net Worth
Last updated:
What is William Charles Banyai Ph.D. net worth?
The estimated net worth of Dr. William Charles Banyai Ph.D. is at least $48,779,694 as of 3 May 2024. He owns shares worth $9,814,385 as insider, has earned $35,196,589 from insider trading and has received compensation worth at least $3,768,720 in Twist Bioscience Corporation.
What is the salary of William Charles Banyai Ph.D.?
Dr. William Charles Banyai Ph.D. salary is $628,120 per year as Senior Vice President of Advanced Devel., GM of Data Storage & Director in Twist Bioscience Corporation.
How old is William Charles Banyai Ph.D.?
Dr. William Charles Banyai Ph.D. is 70 years old, born in 1955.
What stocks does William Charles Banyai Ph.D. currently own?
As insider, Dr. William Charles Banyai Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Twist Bioscience Corporation (TWST) | Senior Vice President of Advanced Devel., GM of Data Storage & Director | 345,188 | $28.43 | $9,814,385 |
What does Twist Bioscience Corporation do?
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.
William Charles Banyai Ph.D. insider trading
Twist Bioscience Corporation
Dr. William Charles Banyai Ph.D. has made 61 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently he sold 798 units of TWST stock worth $29,633 on 3 May 2024.
The largest trade he's ever made was exercising 28,181 units of TWST stock on 13 Oct 2021. As of 3 May 2024 he still owns at least 345,188 units of TWST stock.
Twist Bioscience key executives
Twist Bioscience Corporation executives and other stock owners filed with the SEC:
- Dr. Emily Marine Leproust Ph.D. (52) Co-Founder, Chairman, Pres & Chief Executive Officer
- Dr. Patrick John Finn Ph.D. (53) Chief Commercial Officer
- Dr. William Charles Banyai Ph.D. (70) Senior Vice President of Advanced Devel., GM of Data Storage & Director
- Mr. James M. Thorburn (69) Chief Financial Officer
- Mr. Patrick Weiss (54) Chief Operating Officer